Role of high endothelial postcapillary venules and selected adhesion molecules in periodontal diseases: A review

Journal of Periodontal Research

Volumn 48, Issue 1, 2013, Pages 1-21

  Kasprzak, A ^a   Surdacka, A ^a   Tomczak, M ^a   Konkol, M ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adhesion molecules; Chronic periodontitis; High endothelial venules

Indexed keywords

CELL ADHESION MOLECULE;

ARTICLE; CAPILLARY; CHRONIC PERIODONTITIS; ENDOTHELIUM CELL; GINGIVA; HUMAN; LYMPH VESSEL ENDOTHELIUM; PATHOLOGY; PHYSIOLOGY; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; VASCULAR ENDOTHELIUM; VASCULARIZATION; VENULE;

CAPILLARIES; CELL ADHESION MOLECULES; CHRONIC PERIODONTITIS; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; ENDOTHELIUM, VASCULAR; GINGIVA; HUMANS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; VENULES;

EID: 84871712631     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2012.01492.x     Document Type: Article

References (230)

1. Thome R. Endothelien als Phagocyten (aus den Lymphdrussen von Macacus cynomalgus). Arch Microsk Anat Entwicklung 1898;52:820-841.
2. Marchesi VT, Gowans JL. The migration of lymphocytes through the endothelium of venules in lymph nodes: an electron microscope study. Proc R Soc Lond B Biol Sci 1964;159:283-290.
3. Gowans JL, Knight EJ. The route of re-circulation of lymphocytes in the rat. Proc R Soc Lond B Biol Sci 1964;159:257-282.
4. Freemont AJ, Jones CJP. Light microscopic, histochemical and ultrastructural studies of human lymph node paracortical venules. J Anat 1983;136:349-362.
5. Freemont AJ. A possible route for lymphocyte migration into diseased tissues. J Clin Pathol 1983;36:161-166.
6. Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-457.
7. Andrews P, Milsom DW, Ford WL. Migration of lymphocytes across specialized vascular endothelium. V. Production of sulphated macromolecule by high endothelial cells in lymph node. J Cell Sci 1982;57:277-292.
8. Tohya K, Umemoto E, Miyasaka M. Microanatomy of lymphocyte-endothelial interactions at the high endothelial venules of lymph nodes. Histol Histopathol 2010;25:781-794.
9. Duijvestijn AM, Kerkhove M, Bargatze RF, Butcher EC. Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies. J Immunol 1987;138:713-719.
10. Wenk EJ, Orlic D, Reith EJ, Rhodin JA. The ultrastructure of mouse lymph node venules and the passage of lymphocytes across their walls. J Ultrastruct Res 1974;47:214-241.
11. Anderson ND, Anderson AO, Wyllie RG. Specialized structure and metabolic activities of high endothelial venules in rat lymphatic tissues. Immunology 1976;31:455-473.
12. Izawa D, Tanaka T, Saito K et al. Expression profile of active genes in mouse lymph node high endothelial cells. Int Immunol 1999;11:1989-1997.
13. Kawashima H. Roles of sulfated glycans in lymphocyte homing. Biol Pharm Bull 2006;29:2343-2349.
14. Murphy-Ullrich JE, Hook M. Trombospondin modulates focal adhesions in endothelial cells. J Cell Biol 1989;109:1309-1319.
15. Wynne SE, Walsh LJ, Seymour GJ. Specialized postcapillary venules in human gingival tissue. J Periodontol 1988;59:328-331.
16. Garlanda C, Dejana E. Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 1997;17:1193-1202.
17. Jalkanen S, Steere AC, Fox I, Butcher EC. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science 1986;233:556-558.
18. Faveeuw C, Preece G, Ager A. Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 2001;98:688-695.
19. Syrjanen KJ. Post-capillary venules of the mouse lymphatic tissues with special reference to the distribution of their endothelial IgG. Exp Pathol 1979;17:134-142.
20. Tanaka T, Ebisuno Y, Kanemitsu N et al. Molecular determinants controlling homeostatic recirculation and tissue-specific trafficking of lymphocytes. Int Arch Allergy Immunol 2004;134:120-134.
21. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998;95:258-263.
22. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000;191:77-88.
23. Thomsen AR, Nansen A, Madsen AN, Bartholdy C, Christensen JP. Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines. Immunol Lett 2003;85:119-127.
24. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004;22:129-156.
25. Umemoto E, Tanaka T, Kanda H et al. Nepmucin, a novel sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow. J Exp Med 2006;203:1603-1614.
26. Tangemann K, Bisrup A, Hemmerich S, Rosen SD. Sulfation of high endothelial venule-expressed ligand for L-Selectin: effects on tethering and rolling of lymphocytes. J Exp Med 1999;190:935-941.
27. Samulowitz U, Kuhn A, Brachtendorf G et al. Human endomucin. Distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope. Am J Pathol 2002;160:1669-1681.
28. Kanda H, Tanaka T, Matsumoto M et al. Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling. Int Immunol 2004;16:1265-1274.
29. Sassetti C, Tangenmann K, Singer MS, Kershaw DB, Rosen SD. Identification of podocalyxin-like protein as a high edothelial venule ligand for L-selectin: parallels to CD34. J Exp Med 1998;187:1965-1975.
30. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol 2006;177:3369-3379.
31. Bistrup A, Tsay D, Shenoy P et al. Detection of a sulfotransferase (HEC-GlcNAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates. Relationship to the MECA-79 epitope. Am J Pathol 2004;164:1635-1644.
32. Hiraoka N, Petryniak B, Nakayama J et al. A novel, high endothelial venule specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34. Immunity 1999;11:79-89.
33. Maly P, Thall A, Petryniak B et al. The α(1, 3)fucosyltrafsferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996;86:613-653.
34. Freemont JA. Functional and biosynthetic changes in endothelial cells of vessels in chronically inflamed tissues: evidence for endothelial control of lymphocyte entry into diseased tissues. J Pathol 1988;155:225-230.
35. Kabel PJ, Voorbij HA, de Haan-Meulman M, Pals ST, Drexhage HA. High endothelial venules present in lymphoid cell accumulations in thyroids affected by autoimmune disease: a study in men and BB rats of functional activity and development. J Clin Endocrinol Metab 1989;68:744-751.
36. Thurston G, Baluk P, McDonald DM. Determinants of endothelial cell phenotype in venules. Microcirculation 2000;7:76-80.
37. Lacorre DA, Baekkevold ES, Garrido I et al. Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 2004;103:4164-4172.
38. Baekkevold ES, Roussigné M, Yamanaka T et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003;163:69-79.
39. Hendriks HR, Eestermans IL. Disappearance and reappearance of high endothelial venules and immigrating lymphocytes in lymph nodes deprived of afferent lymphatic vessels: a possible regulatory role of macrophages in lymphocyte migration. Eur J Immunol 1983;13:663-669.
40. Mebius RE, Brevé J, Duijvestijn AM, Kraal G. The function of high endothelial venules in mouse lymph nodes stimulated by oxazolone. Immunology 1990;71:423-427.
41. Chapple CC, Kumar R, Hunter N. Vascular remodelling in chronic inflammatory periodontal disease. J Oral Pathol Med 2000;29:500-506.
42. Zoellner H, Hunter N. The vascular response in chronic periodontitis. Aust Dent J 1994;39:93-97.
43. Zoellner HF, Hunter N. Vascular expansion in chronic periodontitis. J Oral Pathol Med 1991;20:433-437.
44. Miossec P, Cavender D, Ziff M. Production of Interleukin 1 by human endothelial cells. J Immunol 1986;136:2486-2491.
45. Segal GM, McCal E, Stueve T, Bagby GC Jr. Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity. J Immunol 1987;138:1772-1778.
46. Page RC, Simpson DM, Ammons WF. Host tissue response in chronic inflammatory periodontal disease IV. The periodontal and dental status of a group of aged great apes. J Periodontol 1975;46:144-155.
47. Hess KL, Tudor KS, Johnson JD, Osati-Ashtiani F, Askew DS, Cook-Mills JM. Human and murine high endothelial venule cells phagocytose apoptotic leukocytes. Exp Cell Res 1997;236:404-411.
48. Kekkonen TS, Augustin MT, Mäkinen JM, Kekkonen J, Karttunen TJ. High endothelial venules of the lymph nodes express Fas ligand. J Histochem 2004;52:693-699.
49. Zoellner H, Hunter N. Perivascular hyaline deposits in inflamed gingival tissues. J Oral Pathol Med 1989;18:333-338.
50. Zoellner H, Chapple CC, Hunter N. Microvasculature in gingivitis and chronic periodontitis: disruption of vascular networks with protracted inflammation. Microsc Res Tech 2002;56:15-31.
51. Zoellner H, Hunter N. High endothelial-like venules in chronically inflamed periodontal tissues exchange polymorphs. J Pathol 1989;159:301-310.
52. Kasprzak A, Malkowska A, Hausmann M, Przybyszewska W, Zabel M, Stopa J. Detection of cell phenotypes and pro-inflammatory cytokines (IL-1α, TNF-α, IL-6) in chronic periodontitis using ImmunoMax technique. Pol J Environ Stud 2007;16:328-336.
53. Gemmell E, Feldner B, Seymour GJ. CD45RA and CD45RO positive CD4 cells in human peripheral blood and periodontal disease tissue before and after stimulation with periodontopathic bacteria. Oral Microbiol Immunol 1992;7:84-88.
54. Yamazaki K, Nakajima T, Aoyagi T, Hara K. Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease. J Periodontal Res 1993;28:324-334.
55. Brecx M, Patters MR. Morphology of polymorphonuclear neutrophils during periodontal disease in the cynomolgus monkey. J Clin Periodontol 1985;12:591-606.
56. Pinchback JS, Taylor BA, Gibbins JR, Hunter N. Microvascular angiopathy in advanced periodontal disease. J Pathol 1996;179:204-209.
57. Seymour GJ, Gemmell E, Walsh LJ, Powell RN. Immunohistological analysis of experimental gingivitis in humans. Clin Exp Immunol 1988;71:132-137.
58. Vracko R, Benditt EP. Capillary basal lamina thickening. Its relationship to endothelial cell death and replacement. J Cell Biol 1970;47:281-285.
59. Bonakdar MP, Barber PM, Newman HN. The vasculature in chronic adult periodontitis: a qualitative and quantitative study. J Periodontol 1997;68:50-58.
60. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995;6:230-247.
61. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999;70:848-852.
62. Nielsen JS, McNagny KM. Novel functions of the CD34 family. J Cell Sci 2008;121:3683-3692.
63. Baumhueter S, Singer MS, Henzel W et al. Binding of L-selectin to the vascular sialomucin CD34. Science 1993;262:436-438.
64. Simmons DL, Satterthwaite AB, Tenen DG, Seed B. Molecular cloning of cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 1992;148:267-271.
65. Benedetti F. CD34+ cells: biological aspects. Tumori 1996;82(suppl 2):3-13.
66. Kikuta A, Rosen SD. Localization of ligands for L-selectin in mouse peripheral lymph node high endothelial cells by colloidal gold conjugates. Blood 1994;84:3766-3775.
67. Krause DS, Ito T, Fackler MJ et al. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 1994;84:691-701.
68. Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 1992;12:788-794.
69. Fina L, Molgaard HV, Robertson D et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990;75:2417-2426.
70. Delia D, Lampugnani MG, Resnati M et al. CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. Blood 1993;81:1001-1008.
71. Baumhueter S, Dybdal N, Kyle C, Lasky LA. Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 1994;84:2554-2565.
72. Young PE, Baumhueter S, Lasky LA. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 1995;85:96-105.
73. Drew E, Huettner CS, Tenen DG, McNagny KM. CD34 expression by mast cells: of mice and men. Blood 2005;106:1885-1887.
74. Drew E, Merkens H, Chelliah S, Doyonnas R, McNagny KM. CD34 is specific marker of mature murine mast cells. Exp Hematol 2002;30:1211-1218.
75. Barth PJ, Westhoff CC. CD34+ fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther 2007;3:221-227.
76. Rosen SD. Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am J Pathol 1999;155:1013-1020.
77. Balza E, Castellanbi P, Zijlstra A, Neri D, Zardi L, Siri A. Lack of specificity of endoglin expression for tumour blood vessels. Int J Cancer 2001;94:579-585.
78. Yen BL, Huang HI, Chien CC et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005;23:3-9.
79. Ozbey O, Sahin Z, Acar N, Ustunel I. Distribution of CD105 and CD166 positive cells in the proximal epiphysis of developing rat humerus. Histol Histopathol 2010;25:1437-1445.
80. Kestendjieva S, Kyurkchiev D, Tsvetkova G et al. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int 2008;32:724-732.
81. Perry ME, Brown KA, von Gaudecker B. Ultrastructural identification and distribution of the adhesion molecules ICAM-1 and LFA-1 in the vascular and extravascular compartments of the human palatine tonsil. Cell Tissue Res 1992;268:317-326.
82. Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999;155:20430-20550.
83. Pfeiffer F, Kumar V, Butz S et al. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur J Immunol 2008;38:2142-2155.
84. Ayalon O, Sabanai H, Lampugnani MG, Dejana E, Geiger B. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol 1994;126:247-258.
85. Jin S, Umemoto E, Tanaka T et al. Nepmucin/CLM-9, an Ig domain-containing sialomucin in vascular endothelial cells, promotes lymphocyte transendothelial migration in vitro. FEBS Lett 2008;582:3018-3024.
86. Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 2003;421:748-753.
87. Mamdouh Z, Kreitzer GE, Muller WA. Leukocyte transmigration requires kinesin-mediated microtubule-dependent membrane trafficking from the lateral border recycling compartment. J Exp Med 2008;205:951-966.
88. Brown KA, Perry ME, Mustapha Y, Rothlein R, Dumonde DC. Immuno-electron microscopic analysis of the distrubution of ICAM-1 in human inflammatory tissue. Agents Actions 1993; 38(Spec No):C35-C38.
89. Tanaka H, Saito S, Sasaki H, Arai H, Oki T, Shioya N. Morphological aspects of LFA-1/ICAM-1 and VLA-4/VCAM-1 adhesion pathways in human lymph nodes. Pathol Int 1994;44:268-279.
90. Chaitanya GV, Franks SE, Cromer W et al. Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro. Lymphat Res Biol 2010;8:155-164.
91. Streeter PR, Rouse BT, Butcher EC. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 1988;107:1853-1862.
92. Gumina RJ, Kirschbaum NE, Rao PN, VanTuinen P, Newman PJ. The human PECAM-1 gene maps to 17q23. Genomics 1996;34:229-232.
93. Newman PJ. The biology of PECAM-1. J Clin Invest 1997;99:3-8.
94. Sun QH, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 1996;271:11090-11098.
95. Xie Y, Muller WA. Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Cell Biol 1993;90:5569-5573.
96. Newman PJ, Hillery CA, Albrecht R et al. Activation-dependent changes in human platelet PECAM-I: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol 1992;119:239-246.
97. Newman PJ, Berndt MC, Gorski J et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:1219-1222.
98. DeLisser HM, Christofidou-Solomidou M, Strieter RM et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 1997;151:671-677.
99. Zocchi MR, Poggi A. PECAM-1, apoptosis and CD34+ precursors. Leuk Lymphoma 2004;45:2205-2213.
100. Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003;23:953-964.
101. Sheibani N, Frazier WA. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell 1998;9:701-713.
102. Goldberger A, Middleton KA, Oliver JA et al. Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem 1994;269:17183-17191.
103. Tang DG, Chen YQ, Newman PJ et al. Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem 1993;268:22883-22894.
104. Tanaka Y, Albelda SM, Horgan KJ et al. CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med 1992;176:245-253.
105. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994;15:490-495.
106. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCam/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:1059-1068.
107. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449-460.
108. Bogen S, Pak J, Garifallou M, Deng X, Muller WA. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 1994;179:1059-1064.
109. Vaporciyan AA, DeLisser HM, Yan HC et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993;262:1580-1582.
110. Duncan GS, Andrew DP, Takimoto H et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficent mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 1999;162:3022-3030.
111. Cao G, O'Brien CD, Zhou Z et al. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol Cell Physiol 2002;282:C1181-C1190.
112. Tachezy M, Reichelt U, Melenberg T, Gebauer F, Izbicki JR, Kaifi JT. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Histol Histopathol 2010;25:1239-1246.
113. Yan H, Scott Baldwin S, Sun J, Buck CA, Albelda SM, DeLisser HM. Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem 1995;270:23672-23680.
114. O'Brien CD, Ji G, Wang YX et al. PECAM-1 (CD31) engagement activates a phosphoinositide-independent, nonspecific cation channel in endothelial cells. FASEB J 2001;15:1257-1260.
115. Muller WA. The use of anti-PECAM reagents in the control of inflammation. Agents Actions Suppl 1995;46:147-157.
116. Cheifetz S, Bellon T, Cales C et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992;267:19027-19030.
117. Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 1990;265:8361-8364.
118. Fernàndez-Ruiz E, St-Jacques S, Bellón T, Letarte M, Bernabéu C. Assignment of the human endoglin gene (END) to 9q34→qter. Cytogenet Cell Genet 1993;64:204-207.
119. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 1991;67:785-795.
120. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily. J Biol Chem 1999;274:584-594.
121. Bernabeu C, Conley BA, Vary CP. Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 2007;102:1375-1388.
122. Lastres P, Letamendia A, Zhang H et al. Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol 1996;133:1109-1121.
123. Li C, Hampson L, Kumar P, Bernabeu C, Kumar S. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J 2000;14:55-64.
124. Kumar S, Ghellal A, Li C et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999;59:856-861.
125. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma. Anticancer Res 1998;18:2701-2710.
126. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003;22:6557-6563.
127. Guerrero-Esteo M, Sànchez-Elsner T, Bernabeu C. Extracellular and cytoplasmic domains of endoglin interact with the TGF-β receptors I and II. J Biol Chem 2002;277:29197-29209.
128. Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 2005;204:574-584.
129. Torsney E, Charlton R, Parums D, Collis D, Arthur HM. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 2002;51:464-470.
130. Burrows FJ, Derbyshire EJ, Tazzari PL et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumours: implications for diagnosis and therapy. Clin Cancer Res 1995;1:1623-1634.
131. Dallas NA, Samuel S, Xia L et al. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008;14:1931-1937.
132. van Laake LW, van den Driesche S, Post S et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006;114:2288-2297.
133. Postiglione L, Di Domenico G, Caraglia M et al. Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: implications in the modulation of cell proliferation. Int J Oncol 2005;26:1193-1201.
134. Gougos A, Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 1988;141:1925-1933.
135. Adam PJ, Clesham GJ, Weissberg PL. Expression of endoglin mRNA and protein in human vascular smooth muscle cells. Biochem Biophys Res Commun 1998;247:33-37.
136. Bühring HJ, Müller CA, Letarte M et al. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 1991;5:841-847.
137. Robledo MM, Hidalgo A, Lastres P et al. Characterization of TGF-beta 1-binding proteins in human bone marrow stromal cells. J Haematol 1996;93:507-514.
138. Yamada Y, Yokoyama S, Wang XD, Fukuda N, Takakura N. Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow nonhematopoietic cells to differentiate into cardiomyocytes. Stem Cells 2007;25:1326-1333.
139. Perlingeiro RC. Endoglin is required for hemangioblast and early hematopoietic development. Development 2007;134:3041-3048.
140. McAllister KA, Grogg KM, Johnson DW et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic teleangiectasia type 1. Nat Gen 1994;8:345-351.
141. Barresi V, Grosso M, Vitarelli E, Granese R, Barresi G. Endoglin (CD105) immuno- expression in human foetal and neonatal lungs. Histol Histopathol 2008;23:701-708.
142. Conley BA, Koleva RI, Smith JD et al. Endoglin controls cell migration and composition of focal adhesions. J Biol Chem 2004;279:27440-27449.
143. Sanz-Rodriguez F, Guerrero-Esteo M, Borella LM, Banville D, Vary CPH, Bernabeu C. Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 2004;279:32858-32868.
144. Meng Q, Lux A, Holloschi A et al. Identification of Tctex2beta a novel dynein light chain family member interacting with different TGF-beta receptors. J Biol Chem 2006;281:37069-37080.
145. Muenzner P, Rohde M, Kneitz S, Hauck CR. CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J Cell Biol 2005;170:825-836.
146. Cook-Mills JM, Gallagher JS, Feldbush TL. Isolation and characterization of high endothelial cell lines derived from mouse lymph nodes. In Vitro Cell Dev Biol Anim 1996;32:167-177.
147. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-933.
148. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996;74:13-33.
149. Bossy D, Mattei MG, Simmons DL. The human intercellular adhesion molecule 3 (ICAM3) gene is located in the 19p13.2-p13.3 region, close to the ICAM1 gene. Genomics 1994;23:712-713.
150. Kilgannon P, Turner T, Meyer J, Wisdom W, Gallatin WM. Mapping of the ICAM-5 (telencephalin) gene, a neuronal member of the ICAM family, to a location between ICAM-1 and ICAM-3 on human chromosome 19p13.2. Genomics 1998;54:328-330.
151. Kirchhausen T, Staunton DE, Springer TA. Location of the domains of ICAM-1 by immunolabeling and single-molecule electron microscopy. J Leukoc Biol 1993;53:342-346.
152. Cook-Mills JM, Deem TL. Active participation of endothelial cells in inflammation. J Leukoc Biol 2005;77:487-495.
153. Simmons D, Makgoba MW, Seed B. ICAM, and adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 1988;331:624-627.
154. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987;51:813-819.
155. Staunton DE, Dustin ML, Ericson HP, Springer TA. The arrangement of the immunoglubulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990;61:243-254.
156. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 1993;120:1031-1043.
157. Bella J, Kolatkar PR, Marlor CW, Greve JM, Rossmann MG. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci USA 1998;95:4140-4145.
158. Etienne S, Adamson P, Greenwood J, Strosberg AD, Cazaubon S, Couraud PO. ICAM-1 signalling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol 1998;161:5755-5761.
159. Thompson PW, Randi AM, Ridley AJ. Intercellular adhesion molecule (ICAM-1), but not ICAM-2, activates RhoA and stimulates c-fos and rhoA transcription in endothelial cells. J Immunol 2002;169:1007-1013.
160. Adamson P, Etienne S, Couraud PO, Calder V, Greenwood J. Lymphocyte migration through brain endothelial cell monolayers involves signalling through endothelial ICAM-1 via a rho-dependent pathway. J Immunol 1999;162:2964-2973.
161. Wojciak-Stothard B, Williams L, Ridley AJ. Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering. J Cell Biol 1999;145:1293-1307.
162. Greenwood J, Amos CL, Walters CE et al. Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J Immunol 2003;171:2099-2108.
163. Wang Q, Doerschuk CM. The p38 mitogen-activated protein kinase mediates cytoskeleltal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation. J Immunol 2001;166:6877-6884.
164. Tilghman RW, Hoover RL. The Src-cortactin pathway is required for clustering of E-selectin and ICAM-1 in endothelial cells. FASEB J 2002;16:1257-1259.
165. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-434.
166. Stinchcombe JC, Bossi G, Booth S, Griffiths GM. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001;15:751-761.
167. Berendt AR, McDowall A, Craig AG et al. The binding site on ICAM-1 for Plasmodium faciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site. Cell 1992;68:71-78.
168. Ockenhouse CF, Betageri R, Springer TA, Staunton DE. Plasmodium faciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus. Cell 1992;68:63-69.
169. Lebedeva T, Dustin ML, Sykulev Y. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol 2005;17:251-258.
170. Blaber R, Stylianou E, Clayton A, Steadman R. Selective regulation of ICAM-1 and RANTES gene expression after ICAM-1 ligation on human renal fibroblasts. J Am Soc Nephrol 2003;14:116-127.
171. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147:3788-3793.
172. Hannigan E, O'Connell DPO, Hannigan A, Buckley LA. Soluble cell adhesion molecules in gingival crevicular fluid in periodontal health and disease. J Periodontol 2004;75:546-550.
173. Molè N, Kennel-de March A, Martin G, Miller N, Bènè MC, Faure GC. High levels of soluble intercellular adhesion molecule-1 (ICAM-1) in crevicular fluid of periodontitis patients with plaque. J Clin Periodontol 1998;25:754-758.
174. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon, tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-254.
175. Dustin ML, Springer TA. Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988;107:321-331.
176. Carman CV, Springer TA. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 2004;167:377-388.
177. Shaw SK, Ma S, Kim MB et al. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J Exp Med 2004;200:1571-1580.
178. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow. Blood 2005;106:584-592.
179. Sasaki K, Okouchi Y, Rothkotter HJ, Pabst R. Ultrastructural localization of the intercellular adhesion molecule (ICAM-1) on the cell surface of the high endothelial venules in lymph nodes. Anat Rec 1996;244:105-111.
180. Millan J, Hewlett L, Glyn M, Toomre D, Clark P, Ridley AJ. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat Cell Biol 2006;8:113-123.
181. Tohya K, Kimura M. Ultrastructural evidence of distinctive behavior of L-selection and LFA-1 (αLβ2 integrin) on lymphocytes adhering to the endothelial surface of high endothelial venules in peripheral lymph nodes. Histochem Cell Biol 1998;110:407-416.
182. Shulman Z, Shined V, Klein E et al. Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin. Immunity 2009;30:384-396.
183. Page RC, Beck JD. Risk assessment for periodontal diseases. Int Dent J 1997;47:61-87.
184. Slots J, Kamma JJ, Sugar C. The herpesvirus-Porphyromonas gingivalis-periodontitis axis. J Periodontal Res 2003;38:318-323.
185. Cindrić G, Aurer A, Plancak D, Ljerka J, Girotto M. Lymphocyte subpopulations and the expression of intercellular adhesion molecules in chronic periodontitis. Coll Antropol 2004;28:825-832.
186. Williams RC. Periodontal disease. N Engl J Med 1990;322:373-376.
187. Nedbal W, Tomakidi P, Lehmann MJ, Dörfer C, Kohl A, Sczakiel G. Antisense-mediated inhibition of ICAM-1 expression: a therapeutic strategy against inflammation of human periodontal tissue. Antisense Nucleic Acid Drug Dev 2002;12:71-78.
188. Li X, Tse HF, Yiu KH et al. Increased levels of circulating endothelial progenitor cells in subjects with moderate to severe chronic periodontitis. J Clin Periodontol 2009;36:933-939.
189. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71:1528-1534.
190. Briggs JE, McKeown PP, Crawford VL et al. Angiographically confirmed coronary heart disease and periodontal disease in middle-aged males. J Periodontal 2006;77:95-102.
191. Demmer RT, Desvarieux M. Periodontal infections and cardiovascular disease: the heart of the matter. J Am Dent Assoc 2006;137(suppl 1):14-20.
192. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007;154:830-837.
193. Takeuchi Y, Sakurai K, Ike I, Yoshie H, Kawasaki K, Hara K. ICAM-1-expressing pocket epithelium, LFA-1-expressing T cells in gingival tissue and gingival crevicular fluid as features characterizing inflammatory cell invasion and exudation in adult periodontitis. J Periodontal Res 1995;30:426-435.
194. Taşman F, Daǧdeviren A, Kendir B, Ozçelik B, Ataç A, Er N. Endothelial cell adhesion molecules in human dental pulp: a comparative immunohistochemical study on chronic periodontitis. J Endod 1999;25:664-667.
195. Yun P, Decarlo A, Chapple C, Hunter N. Functional implication of the hydrolysis of platelet endothelial cell adhesion molecule 1 (CD31) by gingipains of Porphyromonas gingivalis for the pathology of periodontal disease. Infect Immun 2005;73:1386-1398.
196. Crawford JM. Distribution of ICAM-1, LFA-3 and HLA-DR in healthy and diseased gingival tissues. J Periodontal Res 1992;27:291-298.
197. Gemmel E, Walsh LJ, Savage NW, Seymour GJ. Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res 1994;29:46-53.
198. Tonetti MS, Imboden MA, Lang NP. Neutrophil migration into the gingival sulcus is associated with transepithelial gradients of interleukin-8 and ICAM-1. J Periodontol 1998;69:1139-1147.
199. Konopka T, Kopeć W, Zietek M, Mikulewicz M. Serum levels of soluble adhesion molecules in periodontitis. Pol J Environ Stud 2007;16(6C):135-140.
200. Tancharoen S, Matsuyama T, Abeyama K et al. The role of water channel aquaporin 3 in the mechanism of TNF-alpha-mediated proiflammatory events: implication in periodontal inflammation. J Cell Physiol 2008;217:338-349.
201. Zhang D, Zheng H, Zhao J et al. Porphyromonas gingivalis induces intracellular adhesion molecule-1 expression in endothelial cells through the nuclear factor-kappaB pathway, but not through the p38 MAPK pathway. J Periodontal Res 2011;46:31-38.
202. Yan P, Yue J, Jiang H. Expression of ICAM-1/LFA-1 in the pocket area of adult periodontitis. Zhonghua Kou Qiang Yi Xue Za Zhi 1999;43:106-108.
203. Tonetti MS, Gerber L, Lang NP. Vascular adhesion molecules and initial development of inflammation in clinically healthy human keratinized mucosa around teeth and osseointegrated implants. J Periodontal Res 1994;29:386-392.
204. Rezavandi K, Palmer RM, Odell EW, Scott DA, Wilson RF. Expression of ICAM-1 and E-selectin in gingival tissues of smokers and non-smokers with periodontitis. J Oral Pathol Med 2002;1:59-64.
205. Ihan Hren N, Gubina M, Kozelj V, Ihan A. Immune response in chronic periapical parodontitis. Pflugers Arch 2000;440:R86-R88.
206. Tada H, Sugawara S, Nemoto E et al. Proteolysis of ICAM-1 on human oral epithelial cells by gingipains. J Dent Res 2003;82:796-801.
207. Tamai R, Asai Y, Ogawa T. Requirement for intercellular adhesion molecule 1 and caveolae in invasion of human oral epithelial cells by Porphyromonas gingivalis. Infect Immun 2005;73:6290-6298.
208. Takeshi T, Keisuke N, Takaaki I, Makoto Y, Tatsuji N. Involvement of adhesion molecule in in vitro plaque-like formation of macrophages stimulated with Aggregatibacter actinomycetemcomitans lipopolysaccharide. J Periodontal Res 2010;45:550-556.
209. Park HJ, Jeong SK, Kim SR et al. Resveratrol inhibits Porphyromonas gingivalis lipopolysaccharide-induced endothelial adhesion molecule expression by supressing NF-kappaB activation. Arch Pharm Res 2009;32:583-591.
210. Mirbod SM, Ahing SI, Pruthi VK. Immunohistochemical study of vestibular gingival blood vessel density and internal circumference in smokers and non-smokers. J Periodontol 2001;72:1318-1323.
211. Aimetti M, Romano F, Marsico A, Navone R. Non-surgical periodontal treatment of cyclosporin A-induced gingival overgrowth: immunohistochemical results. Oral Dis 2008;14:244-250.
212. Ohta S, Yamada S, Matuzaka K, Inoue T. The behavior of stem cells and progenitor cells in the periodontal ligament during wound healing as observed using immunohistochemical methods. J Periodontal Res 2008;43:595-603.
213. Nakamura K, Honda K, Mizutani T, Akiho H, Harada N. Novel strategies for the treatment of inflammatory bowel disease: selective inhibition of cytokines and adhesion molecules. World J Gastroenterol 2006;12:4628-4635.
214. Kollum M, Hoefet I, Schreiber R, Bode C, Hehrlein C. Systemic application of anti-ICAM-1 monoclonal antibodies to prevent restenosis in rabbits: an anti-inflammatory strategy. Coron Artery Dis 2007;18:117-123.
215. Elknerová K, Lacinová Z, Soucek J, Marinov I, Stöckbauer P. Growth inhibitory effect of the antibody to hematopoietic stem cell antigen CD34 in leukemic cell lines. Neoplasma 2007;54:311-320.
216. Slatter MA, Brigham K, Dickinson AM et al. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency. J Allergy Clin Immunol 2008;121:361-367.
217. Rotmans JI, Heiligers JM, Verhagen HJ et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005;112:12-18.
218. Nakazawa G, Granada JF, Alviar CL et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv 2010;3:68-75.
219. Rijcken E, Mennigen RB, Schaefer SD et al. PECAM-1 (CD31) mediates transendothelial leukocyte migration in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G446-G452.
220. Ahmadvand D, Rasaee MJ, Rahbarizadeh F, Mohammadi M. Production and characterization of a high-affinity nanobody against human endoglin. Hybridoma (Larchmt) 2008;27:353-360.
221. Seon BK, Haba A, Matsuno F et al. Endoglin-targeted cancer therapy. Curr Drug Deliv 2011;8:135-143.
222. van Assche G, Rutgeerts P. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2005;288:G169-G174.
223. van Assche G, Rutgeerts P. Antiadhesion molecule therapy in inflammatory bowel disease. Inflamm Bowel Dis 2002;8:291-300.
224. Harning R, Pelletier J, Van G, Takei F, Merluzzi VJ. Monoclonal antibody to MALA-2 (ICAM-1) reduces acute autoimmune nephritis in kdkd mice. Clin Immunol Immunopathol 1992;64:129-134.
225. Rothlein R, Jaeger JR. Treatment of inflammatory diseases with a monoclonal antibody to intercellular adhesion molecule 1. Ciba Found Symp 1995;189:200-208. discussion 208-11.
226. Marioni G, D'Alessandro E, Giacomelli L, Staffieri A. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma. J Oral Pathol Med 2010;39:361-367.
227. Vuorte J, Lindsberg PJ, Kaste M et al. Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 1999;162:2353-2357.
228. Sun Z, Wang X, Lasson A, Böjesson A, Annborn M, Andersson R. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. Scand J Gastroenterol 2001;36:55-65.
229. Kasprzak A, Surdacka A, Tomczak M et al. Analysis of marker expression in high endothelial venules in chronic periodontitis. Adv Clin Exp Med 2011;20:275-284.
230. Tomczak M. Expression of gingival blood vessels antigens in chronic periodontitis. Poznan: Poznan University of Medical Sciences, 2011. 131pp. Dissertation.